Indications for Undergoing OGTT in the Flat OGTT Group
| Indication for OGTT . | Entire Cohort (N = 2,085) . | Flat OGTT (n = 98) . |
|---|---|---|
| Abnormal GCT* | 1,165 (55.9) | 14 (14.3) |
| Normal GCT and late indication for GDM† | 212 (10.2) | 24 (24.5) |
| OGTT instead of GCT due to risk factors‡ | 708 (33.9) | 60 (61.2) |
| Indication for OGTT . | Entire Cohort (N = 2,085) . | Flat OGTT (n = 98) . |
|---|---|---|
| Abnormal GCT* | 1,165 (55.9) | 14 (14.3) |
| Normal GCT and late indication for GDM† | 212 (10.2) | 24 (24.5) |
| OGTT instead of GCT due to risk factors‡ | 708 (33.9) | 60 (61.2) |
Data are n (%).
GCT >140 mg/dL.
Late indications for performing OGTT after normal GCT include polyhydramnios or large-for-gestational-age fetus.
Risk factors regarded as indications for direct OGTT include previous GDM, previous macrosomia, strong family history of diabetes, and obesity.